Respiratory Pathogen Detection Kit

Your Leading Respiratory Pathogen Detection Kit Supplier

Amp-Future Biotech specializes in the development, production, and sales of isothermal nucleic acid amplification reagents. Our proprietary MIRA technology (Multienzyme Isothermal Rapid Amplification) ensures fast, accurate, and portable molecular detection, suitable for on-site testing in diverse fields including clinical, agriculture, veterinary , food safety and genetic technologies.

Why choose us?

01.

Our certifications

We has obtained certifications such as NMPA, CE, and the Veterinary Drug Registration License etc.

02.

Our factory

The company is equipped with advanced facilities and operates a class 100,000 cleanroom environment. With an annual reagent production capacity exceeding 90 million tests.

03.

Sales market

Our business footprint covers the entire domestic market and extends across Europe, North America, Middle East and Asia.

04.

Custom service

We can undertake independent and joint development of projects, OEM/ODM. Primer probe design, guidance, synthesis and other services.

Types of Respiratory Pathogen Detection Kit

MIRA SARS-CoV-2 N Gene/reference RNase P Fluorescence Detection Kit Research Use Only

MIRA SARS-CoV-2 ORF1ab Gene Fluorescence Detection Kit Research Use Only

MIRA SARS-CoV-2 N Gene Fluorescence Detection Kit Research Use Only

MIRA Influenza B Virus Nucleic Acid Test Strip Detection Kit Research Use Only

COVID-19 - An acute respiratory infectious disease. The main manifestations include fever, fatigue and dry cough. Other symptoms might be nasal congestion, runny nose, sore throat, myalgia and diarrhea. Currently, the patients infected by the novel coronavirus are the main source of infection. Asymptomatic infected people can also be an infectious source.

Influenza (flu) - Contagious respiratory illness caused by influenza viruses. Influenza viruses can cause mild to severe illness. Some people, such as older people, young children, and people with certain underlying health conditions, are at higher risk for serious flu complications. There are two main types of influenza viruses: types A B. Both type A and B influenza viruses regularly spread among people, and are responsible for seasonal flu each year.

Respiratory Syncytial Virus (RSV) - The most common virus that causes lower respiratory tract infection in infants and young children. It is mainly transmitted by droplet or direct contact, and the population is generally susceptible. The peak season is from November to April.

Human Adenoviruses - Comprise an important group of etiologic agents that are responsible for various diseases in adults and children, such as respiratory, ocular, gastroenteric, and urinary infections. In immunocompromised and organ-transplanted individuals, these agents can cause generalized infections.

Mycoplasma pneumoniae - Infection has a worldwide distribution. It occurs through - out the year, most frequently in the colder months. Clinical diagnosis of M.pneumoniae infection is frequently hindered by a lack of specific signs and symptoms, although in the majority of cases increasing cough, malaise, low-grade fever and headache are reported.

Chlamydia pneumoniae - Causes infections of the upper and lower respiratory tract and in most cases, infections occur with mild symptoms or asymptomatic. C. pneumoniae usually spreads by airborne droplets and in a nearby person-to-person contact. Primary infection occurs mainly in children in school or young people, and cases of reinfection occur mainly in elderly people.

Human parainfluenza viruses (PIV) are a type of virus that often causes lower respiratory tract infections in children, the human parainfluenza virus can cause recurrent upper respiratory tract infections (such as colds and sore throat). It can also cause severe recurrent lower respiratory tract diseases (such as pneumonia, bronchitis, and bronchiolitis), especially in the elderly and immunocompromised population.

Key Features

Broad-spectrum detection

Tests for critical respiratory viruses: COVID-19, Influenza A, Influenza B, and RSV, which are essential for appropriate response and treatment.

High precision and accuracy

Employs advanced molecular techniques to ensure reliable detection and quantification of viral load.

Non-invasive sampling

Utilizes a sponge saliva collection device, making the sample collection process easy, comfortable, and hygienic.

Rapid results

Delivers results within days, enabling fast decision-making and peace of mind during flu seasons and pandemics.

Benefits

Early detection

Identifies infections early to help manage symptoms more effectively and reduce the spread of illness.

All-in-one convenience

Tests multiple pathogens with a single sample, eliminating multiple tests and visits to healthcare facilities.

User-friendly experience

From sample collection to result interpretation, the entire process is designed with your convenience and safety in mind.

Technical Parameters

Parameter	Value
Product Name	SARS-CoV-2 Detection NFO Kit
Manufacturer	Amp-future
Target Gene	N Gene
Sample Type	Nasopharyngeal Swab
Detection Limit	500-1000copies/µL
Test Time	5-20mins
Storage Temperature	-20°C
Packaging	48 Tests/kit
Kit Components	Primers, Probes, Enzymes, Buffers
Shipping	Ice

Custom process

productcate-553-365

Collaborative Partners

productcate-1-1

FAQ

Q: How is the test used?

A: Respiratory pathogens panels may be used to help diagnose the cause of your respiratory infection and help guide treatment. They are used primarily for people who are seriously ill, hospitalized, and/or are at an increased risk for a severe infection with complications or multiple infections at the same time (co-infection).
Many individuals with respiratory infections are never tested because:
Many respiratory infections in otherwise healthy people resolve with no specific treatment and with only supportive care (e.g., getting plenty of rest and drinking plenty of fluids).
When it is strongly suspected you have the flu (it is flu season and the flu is widespread in your community), your healthcare practitioner may make the diagnosis based on your symptoms and treat you with an antiviral medication.
For people with serious illness or at risk of complications, respiratory pathogen panels can help determine whether an infection is due to a virus or bacteria that can be treated with medication.
The panels can diagnose the flu and rule out other illnesses. This can reduce the chances of people using unnecessary antibiotics (which are not effective for viral infections), while increasing the chances that they will receive anti-viral therapy early in the illness, when it is most effective.
Some panels can diagnose infections caused by bacteria that may require treatment with antibiotics.
Respiratory pathogen panels are not used to test all respiratory infections or symptomatic patients. Other types of tests include:
Individual molecular tests for influenza and respiratory syncytial virus (RSV) and other respiratory viruses and bacteria may be performed at the point of care, such as a healthcare practitioner’s office or medical clinic.
Rapid antigen tests for influenza and RSV may also be at the point of care during cold and flu season, even though they can be less sensitive than newer molecular tests.

Q: What other lab tests might be done?

A: Since there are many causes of respiratory infections, and respiratory pathogen panels test for upper respiratory infections, they may be used in conjunction with other tests, such as a bacterial sputum culture, Gram stain, or sometimes a viral culture to help confirm a diagnosis and guide treatment decisions.

Q: Why would my health care provider order additional tests?

A: Additional testing may be done to confirm a positive result using another method, to perform susceptibility testing when the infection is caused by bacteria, or because the cause of your symptoms has not yet been identified.

Q: Can I test negative and still have a respiratory infection?

A: Yes. You can have an infection but a negative result if:
The test does not detect the virus or bacterial strain causing your infection
There was not enough genetic material in the sample to allow it to be detected
The microbe is a new strain that the test cannot reliably detect
Your sample was not properly collected

Q: How can I prevent a respiratory infection?

A: Not every respiratory infection can be prevented, but you can take precautions, such as avoiding close contact with sick people, washing your hands thoroughly and often with soap and water or using a hand sanitizer with at least 60% alcohol, and cleaning and disinfecting surfaces that are touched often and by many people, such as door knobs, counters, toys, etc.
To help prevent the flu, the Centers for Disease Control and Prevention (CDC) recommends annual influenza vaccination for everyone 6 months and older.

We're professional respiratory pathogen detection kit manufacturers and suppliers in China, specialized in providing high quality customized service. If you're going to buy respiratory pathogen detection kit at competitive price, welcome to get quotation and free sample from our factory.

marketing kits, international sale kits, Influenza A Virus Fluorescence Detection Kit